RESUMEN
Zoom Image Abstract Introduction Penile carcinoma is an aggressive disease with catastrophic consequences that frequently lead to death. Therefore, further knowledge on the prognostic factors that can help identify patients in need of more aggressive treatments becomes essential. Objective To identify the prognostic factors for lymph node (LN) involvement and tumor recurrence in patients diagnosed with squamous cell carcinoma of the penis (SCCP). Methods A retrospective cohort study was conducted. Patients diagnosed and treated for SCCP at Instituto Nacional de Cancerología between 2008 and 2015 were included in the sample. Cases in which no information on recurrence was available for the follow-up were excluded, as well as patients with no initial pathology and those getting penile reconstructions after cancer. Relevant data was retrieved from the medical records of each patient, and a descriptive analysis was performed. Subsequently, this data was used to apply a logistic regression model to determine the potential clinical and histopathological prognostic factors. Results A total of 104 patients were included in the present study. The average age of the sample was 59 years, while the follow-up averaged 24 months per patient. Inguinal lymphadenectomy was performed on 61 patients (59%) during the follow-up. The logistic regression model showed that lymphovascular invasion (odds ratio [OR]: 6.7; 95% confidence interval [95%CI]: 1.235) and poor tumor differentiation (OR: 17; 95%CI: 3.292) were associated with tumor recurrence. Likewise, the lymphadenectomy procedures showed that lymphovascular invasion was associated with LN involvement (OR: 3.3; 95%CI: 1.110). Conclusion Lymphovascular invasion was the strongest prognostic factor observed in our sample, aiding in the prediction of inguinal LN involvement and tumor recurrence in SCCP patients
Introduccion El cáncer de pene es una enfermedad agresiva con consecuencias catastróficas que frecuentemente llevan a la muerte. Por lo tanto, es esencial un mayor conocimiento sobre los factores pronósticos que pueden ayudar a identificar a los pacientes que necesitan tratamientos más agresivos. Objetivo Identificar los factores pronósticos patológicos de compromiso ganglionar inguinal y recaída tumoral en pacientes con carcinoma escamocelular de pene. Métodos Se realizó un estudio de cohorte retrospectivo. Se incluyeron en la muestra pacientes diagnosticados y tratados por carcinoma escamocelular de pene (SCCP) en el Instituto Nacional de Cancerología entre 2008 y 2015. Los casos en los que no había información sobre la recurrencia en el seguimiento fueron excluidos, así como los pacientes sin patología inicial y aquellos que reciben reconstrucciones del pene después del cáncer. Se recuperaron los datos relevantes de los registros médicos de cada paciente, y una descripción fue realizada. Posteriormente, estos datos se utilizaron para aplicar un modelo de regresión logística para determinar los posibles factores pronósticos clínicos e histopatológicos. Resultados Un total de 104 pacientes fueron incluidos en el estudio. La edad promedio de la muestra fue de 59 años, mientras que el seguimiento promedió fue de 24 meses por paciente. La linfadenectomía inguinal se realizó en 61 pacientes (59%) durante el seguimiento. El modelo de regresión logística mostró que la invasión linfovascular (odds ratio [OR]: 6,7; intervalo de confianza del 95% [IC 95%]: 1,235) y la pobre diferenciación tumoral (OR: 17; IC 95%: 3,292) se asociaron con recurrencia tumoral. Así mismo, los procedimientos de linfadenectomía mostraron que la invasión linfovascular se asoció con afectación de LN. (OR: 3,3; IC 95%: 1,1-10). Conclusión La invasión linfovascular es el factor pronóstico independiente más importante que se asocia de manera independiente con compromiso ganglionar inguinal positivo y recaída tumoral.
Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Neoplasias del Pene , Escisión del Ganglio Linfático , Patología , Carcinoma , Carcinoma de Células Escamosas , Oportunidad Relativa , Ganglios Linfáticos , Oncología MédicaRESUMEN
Objective To analyze the prognostic factors in the surgical treatment of hilar cholangiocarcinoma.Methods The retrospective case-control study was conducted.The clinicopathological data of 93 patients [61 males and 32 females,age (64±8)years with the range of 43-84 years] with hilar cholangiocarcinoma who underwent surgical treatments in the General Hospital of the Northern Theater from January 2010 to December 2017 were collected.According to preoperative different staging and intraoperative exploration of hilar cholangiocarcinoma,corresponding operations were performed.Observation indicators:(1) surgical treatment situations;(2) tumor typing,staging and degree of differentiation:① tumor typing and staging,② degree of tumor differentiation;(3) follow-up situations;(4) analysis of prognostic factors:① univariate analysis,② multivariate analysis;(5) subgroup analysis.Follow-up using outpatient examination and telephone interview was performed to detect survival time and survival rate of patients up to December 31,2017.Kaplan-Meier method was used to calculate survival time and survival rate and to draw survival curves.Survival situations were analyzed byLog-rank test.The univariate analysis and multivariate analysis were performed using the Log-rank test and COX proportional hazard model respectively.Results (1) Surgical treatment situations:93 patients underwent surgical treatments,including 51 undergoing radical resection,23 undergoing palliative resection,16 undergoing internal biliary drainage or external drainage,3 undergoing abdominal laparotomy and intraoperative biopsy.(2) Tumor typing,staging and degree of differentiation.① Tumor typing and staging:of the 93 patients with hilar cholangiocarcinoma,Bismuth-Corlette type Ⅰ,Ⅱ,Ⅲa,Ⅲb and Ⅳ were detected in 26,22,9,18 and 18 patients.TNM stage Ⅰ,Ⅱ,Ⅲ and Ⅳ were detected in 7,34,22 and 30 patients,Mayo Clinic stage 1,2,3,4 were detected in 20,19,51 and 3 patients.② Degree of tumor differentiation:results of pathological examination showed 16 of 93 patients with highly differentiated adenocarcinoma,35 with moderately differentiated adenocarcinoma,37 with poorly differentiated adenocarcinoma,4 with mucinous adenocarcinoma and 1 with papillary adenocarcinoma.(3) Follow-up situations:93 patients were followed up for 6-36 months,with a median time of 24 months.The survival time of 93 patients was (21.4±2.1)months and the 1-,2-,3-year overall survival rates were 62.2％,34.9％ and 17.1％,respectively.(4) Analysis of prognostic factors:① results of univariate analysis showed that preoperative level of TBil,preoperative level of CA19-9,preoperative level of CA24-2,surgical methods,lymph node metastasis,vascular invasion,TNM staging,Mayo Clinic staging,degree of tumor differentiation were related factors affecting prognosis of patients with hilar cholangiocarcinoma (x2 =6.321,7.357,6.590,22.088,11.173,22.914,23.326,25.966,39.512,P＜0.05).② Results of multivariate analysis showed that preoperative level of TBil,preoperative level of CA 19-9,surgical methods,vascular invasion and degree of tumor differentiation were independent factors affecting prognosis of patients with hilar cholangiocarcinoma (odds ratio=1.002,1.001,2.690,2.626,0.420,95％ confidence interval:1.000-1.004,1.000-1.002,1.474-4.910,1.333-5.134,0.206-0.854,P＜0.05).(5) Subgroup analysis:of the 93 patients,the survival time of 51 undergoing radical resection was (28.0±2.3)months,and the 1-,2-,3-year survival rates were 75.3％,57.5％ and 25.7％,respectively;the survival time of 23 undergoing palliative resection was (14.0±2.4)months and the 1-,2-,3-year survival rates were 60.9％,13.0％,0,respectively;the survival time of 19 undergoing biliary drainage or open exploration was (8.0±2.9) months and the 1-,2-,3-year survival rates were 31.6％,7.9％,0,respectively.The survival of patients undergoing radical resection was significantly different from that of patients undergoing palliative resection,biliary drainage and open laparotomy respectively (x2 =10.939,18.343,P＜0.05).The survival of patients undergoing palliative resection was not statistically significant different from that of patients undergoing biliary drainage or exploration group (x2 =2.803,P＞0.05).Of the 35 patients with vascular invasion,the overall survival time was (7.0±2.0)months and 1-,2-,3-year survival rates were 14.5％,7.3％,0 respectively in 18 with portal vein invasion only,(10.0± 2.1)months and 37.5％,18.8％,and 18.8％ respectively in 8 with hepatic artery invasion,showing no statistically significant difference between the two groups (x2 =0.905,P＞0.05).Conclusions Preoperative level of TBil,preoperative level of CA19-9,surgical procedures,vascular invasion and degree of tumor differentiation are independent prognostic factors for patients with hilar cholangiocarcinoma.Radical resection can prolong the survival time of patients compared with other surgical treatments.
RESUMEN
Introducción: El grado de diferenciación tumoral, la expresión de los receptores de estrógeno y progesterona y la sobreexpresión de la proteína HER-2/neu son factores de tipo pronóstico y predictivo importantes en la evolución y conducta terapéutica del carcinoma mamario infiltrante. Se ha encontrado en diversos estudios que los inmunofenotipos que no expresan los receptores hormonales o que sobre expresan la proteína HER-2/neu se asocian con pobre diferenciación tumoral. Objetivo: Determinar el perfil inmunofenotípico del carcinoma ductal infiltrante y establecer su relación con el grado de diferenciación tumoral. Metodología: Usando técnicas de inmunohistoquímica se determinaron los receptores de estrógeno (RE) y progesterona (RP), y la sobreexpresión de la proteína HER-2/neu en muestras de carcinoma ductal infiltrante y se identificaron sus fenotipos basados en la clasificación de Cheang. La variedad histológica y el grado de diferenciación tumoral en los carcinomas ductales infiltrantes fueron evaluados en tejido coloreado con hematoxilina-eosina. Resultados: Se incluyeron las muestras de 58 pacientes con carcinoma ductal infiltrante. El 15,5% de los carcinomas eran bien diferenciados, 63,8% moderadamente diferenciados y el 20,7% restante pobremente diferenciados. El inmunofenotipo triple negativo se presentó en 29,3% de las muestras, HER2+ en el 20,7%, luminal/ HER2+ en el 1,7%, luminal A en el 43,1% y ER-/PR+/HER2- en el 5,2%. Conclusión: En nuestro estudio, no se encontró asociación entre el grado de diferenciación tumoral y los inmunofenotipos. Salud UIS 2011; 43 (2): 149-158.
Introduction: The degree of tumor differentiation, the expression of estrogen and progesterone receptors and HER-2/ neu protein overexpressing are important prognostic and predictive factors in the evolution and therapeutic management of invasive breast carcinoma. In different studies were found that the immunophenotypes that do not express hormonal receptors or the HER-2/neu protein overexpressing have been associated with poor tumor differentiation. Purpose: To determine the immunophenotypic profile of invasive ductal carcinoma and establish its relationship with the histological grade. Methodology: Using immunohistochemistry were determined the estrogen receptor (ER) and progesterone (PR) and HER-2/neu protein overexpression in invasive ductal carcinoma samples and their phenotypes were identified based on classification of Cheang. The histological subtype and degree of tumor differentiation in invasive ductal carcinomas were evaluated in tissue stained with hematoxylin-eosin. Results: In this study were included 58 patients with invasive ductal carcinoma. 15.5% of the carcinomas were well differentiated, 63.8% moderately differentiated and the remaining 20.7% poorly differentiated. The triple-negative immunophenotype was show in 29.3% of the samples, HER2+ in the 20.7%, luminal/HER2 + in the 1.7%, luminal A in the 43.1% and the phenotype (ER-/PR+/HER2) in the 5.2%. Conclusion: In this study don't was found association between the degree of tumor differentiation and the immunophenotypes. Salud UIS 2011; 43 (2): 149-158.